HUP0100540A3 - Substituted oximes as neurokinin antagonists - Google Patents
Substituted oximes as neurokinin antagonistsInfo
- Publication number
- HUP0100540A3 HUP0100540A3 HU0100540A HUP0100540A HUP0100540A3 HU P0100540 A3 HUP0100540 A3 HU P0100540A3 HU 0100540 A HU0100540 A HU 0100540A HU P0100540 A HUP0100540 A HU P0100540A HU P0100540 A3 HUP0100540 A3 HU P0100540A3
- Authority
- HU
- Hungary
- Prior art keywords
- neurokinin antagonists
- substituted oximes
- oximes
- substituted
- neurokinin
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 150000002923 oximes Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97593597A | 1997-11-21 | 1997-11-21 | |
| PCT/US1998/023255 WO1999026924A1 (en) | 1997-11-21 | 1998-11-18 | Substituted oximes as neurokinin antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0100540A2 HUP0100540A2 (hu) | 2001-07-30 |
| HUP0100540A3 true HUP0100540A3 (en) | 2002-12-28 |
Family
ID=25523570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0100540A HUP0100540A3 (en) | 1997-11-21 | 1998-11-18 | Substituted oximes as neurokinin antagonists |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1032561B1 (hu) |
| JP (1) | JP3523194B2 (hu) |
| KR (1) | KR20010074420A (hu) |
| CN (1) | CN1122022C (hu) |
| AR (1) | AR016689A1 (hu) |
| AT (1) | ATE259355T1 (hu) |
| AU (1) | AU753582B2 (hu) |
| BR (1) | BR9814987A (hu) |
| CA (1) | CA2309558C (hu) |
| CO (1) | CO4980886A1 (hu) |
| DE (1) | DE69821642T2 (hu) |
| ES (1) | ES2212379T3 (hu) |
| HU (1) | HUP0100540A3 (hu) |
| ID (1) | ID26508A (hu) |
| IL (1) | IL135408A0 (hu) |
| MY (1) | MY116430A (hu) |
| NO (1) | NO20002575L (hu) |
| NZ (1) | NZ503757A (hu) |
| PE (1) | PE134599A1 (hu) |
| PL (1) | PL340544A1 (hu) |
| SK (1) | SK7602000A3 (hu) |
| TR (1) | TR200001437T2 (hu) |
| TW (1) | TW474918B (hu) |
| WO (1) | WO1999026924A1 (hu) |
| ZA (1) | ZA9810550B (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221880B1 (en) * | 1998-10-09 | 2001-04-24 | Schering Corporation | Composition and method for treating allergic diseases |
| US6204265B1 (en) | 1998-12-23 | 2001-03-20 | Schering Corporation | Substituted oximes and hydrazones as neurokinin antagonists |
| CA2355886C (en) * | 1998-12-23 | 2006-10-31 | Schering Corporation | Substituted oximes and hydrazones as neurokinin antagonists |
| TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| EP2117538A1 (en) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US569267A (en) * | 1896-10-13 | Alfeed g | ||
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
| GB9321557D0 (en) * | 1992-11-03 | 1993-12-08 | Zeneca Ltd | Carboxamide derivatives |
| GB9310713D0 (en) * | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Aryl substituted heterocycles |
| GB9317104D0 (en) * | 1993-08-17 | 1993-09-29 | Zeneca Ltd | Therapeutic heterocycles |
| GB9322643D0 (en) * | 1993-11-03 | 1993-12-22 | Zeneca Ltd | Lactam derivatives |
| US5696267A (en) * | 1995-05-02 | 1997-12-09 | Schering Corporation | Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| US5654316A (en) * | 1995-06-06 | 1997-08-05 | Schering Corporation | Piperidine derivatives as neurokinin antagonists |
-
1998
- 1998-11-18 IL IL13540898A patent/IL135408A0/xx unknown
- 1998-11-18 PE PE1998001122A patent/PE134599A1/es not_active Application Discontinuation
- 1998-11-18 AR ARP980105844A patent/AR016689A1/es unknown
- 1998-11-18 AU AU14502/99A patent/AU753582B2/en not_active Ceased
- 1998-11-18 TW TW087119102A patent/TW474918B/zh not_active IP Right Cessation
- 1998-11-18 NZ NZ503757A patent/NZ503757A/en unknown
- 1998-11-18 ID IDW20000867A patent/ID26508A/id unknown
- 1998-11-18 BR BR9814987-3A patent/BR9814987A/pt not_active IP Right Cessation
- 1998-11-18 ZA ZA9810550A patent/ZA9810550B/xx unknown
- 1998-11-18 CA CA002309558A patent/CA2309558C/en not_active Expired - Fee Related
- 1998-11-18 CO CO98067903A patent/CO4980886A1/es unknown
- 1998-11-18 ES ES98958458T patent/ES2212379T3/es not_active Expired - Lifetime
- 1998-11-18 EP EP98958458A patent/EP1032561B1/en not_active Expired - Lifetime
- 1998-11-18 AT AT98958458T patent/ATE259355T1/de not_active IP Right Cessation
- 1998-11-18 WO PCT/US1998/023255 patent/WO1999026924A1/en active IP Right Grant
- 1998-11-18 JP JP2000522082A patent/JP3523194B2/ja not_active Expired - Fee Related
- 1998-11-18 TR TR2000/01437T patent/TR200001437T2/xx unknown
- 1998-11-18 KR KR1020007005503A patent/KR20010074420A/ko active IP Right Grant
- 1998-11-18 CN CN98811396A patent/CN1122022C/zh not_active Expired - Fee Related
- 1998-11-18 MY MYPI98005252A patent/MY116430A/en unknown
- 1998-11-18 PL PL98340544A patent/PL340544A1/xx unknown
- 1998-11-18 DE DE69821642T patent/DE69821642T2/de not_active Expired - Fee Related
- 1998-11-18 HU HU0100540A patent/HUP0100540A3/hu unknown
- 1998-11-18 SK SK760-2000A patent/SK7602000A3/sk unknown
-
2000
- 2000-05-19 NO NO20002575A patent/NO20002575L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL135408A0 (en) | 2001-05-20 |
| AR016689A1 (es) | 2001-07-25 |
| DE69821642T2 (de) | 2004-12-23 |
| ES2212379T3 (es) | 2004-07-16 |
| ZA9810550B (en) | 1999-05-16 |
| WO1999026924A1 (en) | 1999-06-03 |
| EP1032561B1 (en) | 2004-02-11 |
| PE134599A1 (es) | 2000-01-07 |
| KR20010074420A (ko) | 2001-08-04 |
| TW474918B (en) | 2002-02-01 |
| SK7602000A3 (en) | 2001-01-18 |
| JP2001524466A (ja) | 2001-12-04 |
| TR200001437T2 (tr) | 2000-10-23 |
| NZ503757A (en) | 2002-03-01 |
| CO4980886A1 (es) | 2000-11-27 |
| CA2309558C (en) | 2005-05-03 |
| ID26508A (id) | 2001-01-11 |
| AU1450299A (en) | 1999-06-15 |
| MY116430A (en) | 2004-01-31 |
| PL340544A1 (en) | 2001-02-12 |
| EP1032561A1 (en) | 2000-09-06 |
| AU753582B2 (en) | 2002-10-24 |
| BR9814987A (pt) | 2000-10-03 |
| JP3523194B2 (ja) | 2004-04-26 |
| HUP0100540A2 (hu) | 2001-07-30 |
| ATE259355T1 (de) | 2004-02-15 |
| NO20002575D0 (no) | 2000-05-19 |
| CN1279670A (zh) | 2001-01-10 |
| CN1122022C (zh) | 2003-09-24 |
| NO20002575L (no) | 2000-07-20 |
| DE69821642D1 (de) | 2004-03-18 |
| CA2309558A1 (en) | 1999-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0000487A3 (en) | Subsituted oximes derivatives useful as neurokinin antagonists | |
| HU9503402D0 (en) | Neurokinin receptor antagonists | |
| IL150033A0 (en) | Selective neurokinin antagonists | |
| AU5333596A (en) | 3-benzylamino-2-phenylpiperidines as neurokinin antagonists | |
| EP0783498A4 (en) | ARYL SUBSTITUTED PIPERAZINES NEUROKININ ANTAGONISTS | |
| AU3567195A (en) | Neurokinin antagonists | |
| HUP9903590A3 (en) | 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists | |
| IL142045A0 (en) | Naphthalenecarboxamides as tachykinin receptor antagonists | |
| IL134301A0 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists | |
| ZA98256B (en) | Tachykinin antagonists | |
| HK1037182A1 (en) | Substituted oximes and hydrazones as neurokinin antagonists. | |
| IL129660A0 (en) | Piperazino derivatives as neurokinin antagonists | |
| ZA9810550B (en) | Substituted oximes as neurokinin antagonists | |
| GB9705861D0 (en) | Trypthophan ureas as neurokinin antagonists | |
| IL133079A0 (en) | Quaternary ammonium compounds as tachykinin antagonists | |
| HUP9903653A3 (en) | Substituted arylalkylamines as neurokinin antagonists | |
| IL134155A0 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists | |
| ZA99171B (en) | Piperazino derivatives as neurokinin antagonists. | |
| HUP9902810A3 (en) | 1,4-dihydropyridine compounds as bradykinin antagonists | |
| GB9611786D0 (en) | Trypthophan ureas as neurokinin antagonists | |
| IL120313A0 (en) | Piperidine derivatives as neurokinin antagonists | |
| ZA971467B (en) | Piperazino derivatives as neurokinin antagonists. | |
| AU4991697A (en) | Substituted oximes derivatives useful as neurokinin antagonists | |
| ZA9510618B (en) | Tachykinin antagonists |